Detecting, analysing and interpreting diagnostic devices
- 1. Detecting, analysing and interpreting diagnostic devices for use outside clinical laboratories
- 2. Most value provided to diagnostic tests taken in remote locations (in-field) or at the point of patient care (at home) Support patient care within chronic/autoimmune disease monitoring, or to diagnose and track infectious disease Can be applied to almost any visually read tests including: lateral flow, colorimetric, ELISA and agglutination CE-Marked medical products for IBD in Europe & Canada. First FDA 510 (K) approval in the US expected Dec 2018 Patent protected in the US, Europe (includes UK), China, Japan, Russia. Use cases in human clinical, animal health, food safety and environmental ISO 13485:2016 and EIC 62304 compliant About Novarum DX Read and share the results of point of care tests using smartphone reader technology.
- 3. Healthcare institutions overburdened Waiting lists - increasing time to result Geographic barriers to healthcare provision Resource poor settings and infrastructure Inconvenience of recurring appointments Patients too sick to travel Decentralised Healthcare
- 4. Mobile Ecosystem Multi-frame analysis technique provides highly accurate results, whilst removing human subjectivity. Test results shared securely to an end-user portal online. Image-capture technology transforms a mobile phone into a diagnostic test reader the results of which are shared to an end-user portal.
- 5. Step-by-step instruction carousels In-app Videos and voice instruction Incubation timers and alarms Correct sample preparation is achieved using Test Choreography which ensures incubation periods are adhered to - preventing false results. How can errors be prevented?
- 6. Patients can monitor chronic conditions with regular self-testing Bedside testing an option for patients who are too sick to visit their GP Overcomes geographic constraints for patients too remote from healthcare provision Maintains confidentiality and removes the stigma of attending sexual health clinics Enables lay users to have confidence in performing tests Enables clinicians to trust self-tests Point of Care Testing – At Home
- 7. Crohn’s Disease & Ulcerative Colitis The first CE-Marked smartphone- based calprotectin home test measuring the inflammatory marker for faecal calprotectin at home. Mobile App (CalApp®) Desktop Portal (IBDoc®) Data recorded from the portal is shared with trusted end-users, which can include Electronic Healthcare providers to shape the future of healthcare. SOURCE: BÜHLMANN Laboratories AG
- 8. Help to reduce the spread of blood-borne disease with an early diagnosis Support technician fieldwork with quick and accurate test results outside a laboratory Tag test results with a geo-location to track infectious disease outbreaks Enable connected, monitored testing in remote locations Point of Care Testing – In Field
- 9. Rapid diagnosis to distinguish between bacterial and viral infectious Robust traceability for prescriptions to human and food-producing animals Track and trace infectious disease outbreaks to limit its spread Antibiotic Stewardship
- 10. Overestimate the expectations of patients to get a prescription Patients want to feel better Patients don’t want to wait for an appointment if they don’t improve Patients find it easier to accept if there is a test result Prof Klepser @ Ferris State University – extensive research on the role of Community Pharmacists in reducing antibiotic overprescribing Potential for Pharmacists?
- 11. Unlikely to happen without a government driven agenda Requires a joined up ecosystem to manage diagnosis, prescription, care and follow up of antibiotic use Putting patients at centre could transform the approach – and mobile may enable that Viability?
- 12. T: +44(0)131 290 2 290 npolwart@novarumdx.com enquiries@novarumdx.com www.novarumdx.com LT-41_2018_10_22